Advancing In Vivo CAR-T with QSP
Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…
Certara2026 年 5 月 12 日
Certara IQ™ Demo
Watch a short demo of Certara IQ™, a QSP platform for modeling, simulation, and analysis.…
Certara2026 年 5 月 12 日
Understanding quantitative effects of anti-amyloid therapies on tau biomarkers and functional outcome
QSP modeling reveals how anti-amyloid therapies impact tau biomarkers and cognitive outcomes in Alzheimer’s disease.
Certara2026 年 5 月 4 日
Modeling CAR-T Outcomes in Multiple Myeloma
Learn how QSP modeling predicts CAR-T therapy outcomes, identifies patient-specific response drivers, and supports multi-antigen…
Certara2026 年 5 月 4 日
Modeling T-cell Exhaustion in Immunotherapy
Discover how QSP modeling predicts T-cell exhaustion, relapse risk, and optimal dosing strategies for T-cell…
Certara2026 年 5 月 4 日
Modeling Hematopoiesis in MDS and AML with QSP
Discover a mechanistic QSP platform model of hematopoiesis to evaluate therapies in MDS and AML,…
Certara2026 年 5 月 1 日
IO Simulator: A QSP Platform for Immuno-Oncology
This poster showcases how IO Simulator predicts immunotherapy response and supports combination design and biomarker…
Certara2026 年 4 月 30 日
QSP at an Inflection Point: Scaling Impact
The QSP Summit at Certainty US 2026 brought together industry leaders to explore how Quantitative…
Certara2026 年 4 月 29 日
From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development
Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…
Certara2026 年 4 月 28 日
Modeling Hope: From Patient to Scientist Ellen Swanson on QSP, Breast Cancer, and Hope Through Science
Ellen Swanson, QSP Senior Scientist at Certara, shares her personal journey from breast cancer diagnosis…
Certara2026 年 4 月 16 日
